SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 14.99 |
| Enterprise Value ($M) | -6.68 |
| Book Value ($M) | 12.95 |
| Book Value / Share | 1.50 |
| Price / Book | 1.16 |
| NCAV ($M) | 12.74 |
| NCAV / Share | 1.48 |
| Price / NCAV | 1.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.12 |
| Return on Assets (ROA) | -1.22 |
| Return on Equity (ROE) | -1.66 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.41 |
| Current Ratio | 2.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 21.93 |
| Assets | 22.15 |
| Liabilities | 9.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13D/A | Dong-a St Co., Ltd | 54.95 | 118.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,182 | 10,415 | 20.95 | |
| 3,601 | 20,968 | 17.17 | |
| 8,807 | 26,287 | 33.50 | |
| 1,311 | 5,398 | 24.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNPR – Monopar Therapeutics Inc. | MRKR – Marker Therapeutics, Inc. |
| MTEX – Mannatech, Incorporated | MYNZ – Mainz Biomed N.V. |
| NATR – Nature's Sunshine Products, Inc. |
Financial data and stock pages provided by
Fintel.io